首页> 外文期刊>VirusDisease >Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus
【24h】

Computational approach to decipher cellular interactors and drug targets during co-infection of SARS-CoV-2, Dengue, and Chikungunya virus

机译:在SARS-COV-2,登革热和Chikungunya病毒的共同感染过程中破译细胞交互式和药物靶标的计算方法

获取原文
           

摘要

The world is reeling under severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, and it will be frightening if compounded by other co-existing infections. The co-occurrence of the Dengue virus (DENV) and Chikungunya virus (CHIKV) has been into existence, but recently the co-infection of DENV and SARS-CoV-2 has been reported. Thus, the possibility of DENV, CHIKV, and SARS-CoV-2 co-infection could be predicted in the future with enhanced vulnerability. It is essential to elucidate the host interactors and the connected pathways to understand the biological insights. The in silico approach using Cytoscape was exploited to elucidate the common human proteins interacting with DENV, CHIKV, and SARS-CoV-2 during their probable co-infection. In total, 17 interacting host proteins were identified showing association with envelope, structural, non-structural, and accessory proteins. Investigating the functional and biological behaviour using PANTHER, UniProtKB, and KEGG databases uncovered their association with several cellular pathways including, signaling pathways, RNA processing and transport, cell cycle, ubiquitination, and protein trafficking. Withal, exploring the DrugBank and Therapeutic Target Database, total seven druggable host proteins were predicted. Among all integrin beta-1, histone deacetylase-2 (HDAC2) and microtubule affinity-regulating kinase-3?were targeted by FDA approved molecules/ drugs. Furthermore, HDAC2 was predicted to be the most significant target, and some approved drugs are available against it. The predicted druggable targets and approved drugs could be investigated to obliterate the identified interactions that could assist in inhibiting viral infection. Keywords: Cellular interactors, Covid-19, Viral inhibitor, Viral-host protein interactionsIntroductionThe pandemic caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put immense pressure on the health care system and resulted in the indefinite future. Its genome consists of positive single-stranded RNA (genus betacoronavirus ) comprising 14 open reading frames (Orfs) which encodes 16 non-structural proteins (nsP1-16), four structural (S, E, M and N) and nine accessory proteins (orf3a, orf3b, orf6, orf7a, orf7b, orf8, orf9b, orf9c and orf10). SARS-CoV-2 may confound seasons, and its transmission is not dependent on specific temperature conditions [21]. Dengue virus (DENV) and Chikungunya virus (CHIKV) infections become prevalent during monsoon season in tropical and subtropical countries. Mosquito species Aedes aegypti is the major vector for the transmission of DENV as well as CHIKV [45, 55]. There are reports that the severity of the disease is much more than the mono-infection during their co-infection [29, 45, 55]. SARS-CoV-2 and DENV infections have also been reported to share clinical and laboratory features [72]. Accumulated data from Singapore [72], India [3, 25], and Mayotte (Island in the Indian Ocean) [15] suggested that the patients have a probability of being co-infected with SARS-CoV-2 and DENV. A report from Thailand reported that the SARS-CoV-2 patients exhibited symptoms like skin rash with petechiae and low platelet count initially, which are common clinical manifestations during DENV infection [27]. Though the co-infection of CHIKV and SARS-CoV-2 is not reported yet, the probability in the future exists. Furthermore, the co-incidence of DENV, CHIKV, and SARS-CoV-2 at the same time could also be predicted with more severity in DENV/CHIKV predominant areas. SARS-CoV-2 is one of the greatest challenges of recent times, and its interaction with host proteins during co-infection needs to be deciphered.Both DENV and CHIKV are single-stranded RNA viruses that belong to genus flavivirus and alphavirus , respectively [29]. The genome of CHIKV encodes four nsPs (nsP1-4) and five structural proteins (E1, E2, E3, 6?K and C) while DENV encodes seven nsPs (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) and three structural proteins (C, prM, and E) [38, 56].SARS-CoV-2, DENV and CHIKV infections have been strongly associated with marked increase in inflammatory cytokines. Higher concentrations of pro-inflammatory cytokines have been reported in the severely critically ill patients of coronavirus disease (Covid-19) [7, 74]. The cytokine storm was reported to be responsible for the tissue damage (heart, liver, and kidney) and multiple organ failure [14]. Studies have demonstrated the association of cardiovascular manifestations during CHIKV and DENV infections due to enhanced up-regulation of cytokines [1, 57]. Thus, the cytokine storm and the multi-organ dysfunction have been observed during the mono-infections of CHIKV, DENV and SARS-CoV-2.The characterization of interactions between viral and host proteins help to understand the molecular mechanism of infection. Several studies have reported the interactions of human proteins with DENV and CHIKV during mono-infection [14, 33, 43]. However, the
机译:世界上在严重的急性呼吸综合征冠状病毒2(SARS-COV-2)大流行下卷入,如果被其他共同的感染复合,它将是可怕的。登革热病毒(Denv)和Chikungunya病毒(Chikv)的共同发生已经存在,但最近据报道了Denv和SARS-COV-2的共感染。因此,可以在未来预测丹佛,Chikv和SARS-COV-2的可能性,增强脆弱性。必须阐明主机互动者和连接的通道以了解生物洞察。利用Cytoskape的Silico方法被利用,阐明在可能的共同感染期间与DenV,Chikv和SARS-CoV-2相互作用的常见人蛋白。总共鉴定了17个相互作用的宿主蛋白,显示出与包络,结构,非结构和辅助蛋白的关联。研究使用Panther,UniprotkB和Kegg数据库的功能和生物学行为揭示其与几种细胞途径的关联,包括信号传导途径,RNA加工,细胞周期,泛素化和蛋白质运输。耐用,探索药物银行和治疗靶数据库,预测了七种可药剂宿主蛋白。在全部整合蛋白β-1中,组蛋白脱乙酰酶-2(HDAC2)和微管亲和力调节激酶-3?由FDA批准的分子/药物靶向。此外,预计HDAC2是最重要的目标,一些批准的药物可针对它。可以研究预测的可药剂靶和批准的药物,以消除可有助于抑制病毒感染的鉴定的相互作用。关键词:细胞交互式,Covid-19,病毒抑制剂,病毒宿主蛋白相互作用表都是由严重急性呼吸综合征冠状病毒2(SARS-COV-2)引起的大流行,对医疗保健系统施加了巨大的压力,导致了无限期的未来。其基因组由阳性单链RNA(Betacoronavirus)组成,所述阳性单链RNA(Genus Betacoronavirus)包含14个开放阅读框架(ORF),其编码16个非结构蛋白(NSP1-16),四个结构(S,E,M和N)和九种辅助蛋白( ORF3A,ORF3B,ORF6,ORF7A,ORF7B,ORF8,ORF9B,ORF9C和ORF10)。 SARS-COV-2可以混淆季节,其变速器不依赖于特定的温度条件[21]。登革热病毒(DENV)和Chikungunya病毒(Chikv)感染在热带和亚热带国家的季风季节普遍存在。蚊虫物种AEDES AEGYPTI是丹佛传播的主要载体以及CHIKV [45,55]。有报道称,疾病的严重程度远远超过它们在其共感染期间的单声道感染[29,45,55]。据报道,SARS-COV-2和DENV感染分享临床和实验室特征[72]。来自新加坡的累计数据[72],印度[3,25]和Mayotte(印度洋中的岛屿)[15]表明患者有概率与SARS-COV-2和DENV共同感染。来自泰国的一份报告报告说,SARS-COV-2患者最初表现出皮疹和低血小板计数的症状,这是丹佛感染期间的常见临床表现[27]。虽然尚未报告Chikv和SARS-COV-2的共同感染,但未来的可能性存在。此外,也可以在DenV / Chikv主要区域中预测丹佛,Chikv和SARS-COV-2的共发病率。 SARS-COV-2是近期最大的挑战之一,其与宿主蛋白在共感染期间的相互作用需要破解。丹佛和Chikv分别属于黄病毒属和alphavirous的单链RNA病毒[ 29]。 Chikv的基因组编码四个NSP(NSP1-4)和五个结构蛋白(E1,E2,E3,6?K和C),而DENV编码七个NSP(NS1,NS2A,NS2B,NS3,NS4A,NS4B和NS5)和三种结构蛋白(C,PRM和E)[38,56] .sars-cov-2,Denv和Chikv感染与炎症细胞因子的显着增加有关。冠心病病毒疾病(Covid-19)的严重批评患者(Covid-19)的严重危重病人[7,74]中据报道,较高浓度的促炎细胞因子。据报道,细胞因子风暴负责组织损伤(心脏,肝脏和肾脏)和多器官衰竭[14]。研究表明,由于增强细胞因子的上调,CHIKV和DENV感染期间的心血管表现联系[1,57]。因此,在CHIKV,DENV和SARS-COV-2的单次感染期间观察到细胞因子风暴和多器官功能障碍。病毒和宿主蛋白质之间的相互作用的表征有助于了解感染的分子机制。几项研究报告了人类蛋白质与丹佛和Chikv的相互作用在单次感染期间[14,33,43]。然而

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号